Glicerinas Industriales, S.A de C.V – FDA Inspection, May 12, 2023

Record Details

This FDA Inspection record concerns Glicerinas Industriales, S.A de C.V, with an inspection on May 12, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Glicerinas Industriales, S.A de C.V
Inspection Date: May 12, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Ariel Cruz Figueroa (FDA Associated Person)
Khoa Nathan V. Tran (Company Rep)

View Company Profile

ID · a94cdac1-011e-46b8-a753-9341ac1b9928

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1205407
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

21 CFR 211.192Investigations of discrepancies, failures
21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Glicerinas Industriales, S.A de C.V

FDA Inspection

Glicerinas Industriales, S.A de C.VMay 12, 2023